Buyer Beware on Schedule 3 – Descheduling or Bust: Why Half-Measures Won’t Cut It for Cannabis Reform

 Picture this: Donald Trump, the man who rose to fame on a platform of “tough on crime” rhetoric, recently took to social media to discuss the endocannabinoid system and the potential impact of cannabis policies. Yes, you read that correctly. The same guy who once declared himself a staunch opponent of drug use is now delving into the intricacies of CB1 and CB2 receptors. And if that wasn’t enough to make your head spin, he even suggested that covering CBD under Medicare could be the most groundbreaking senior health initiative of our time. I don’t know about you, but if someone had told me this five years ago, I would have assumed they were indulging in a few too many of Colorado’s finest concentrates.